Please login to the form below

Not currently logged in
Email:
Password:

Immunocore appoints chief financial officer

Paul Fry brings leadership experience from GlaxoSmithKline

Oxford, UK-based Immunocore has appointed Paul Fry as its chief financial officer.

Fry has over two decades of senior management experience in the life sciences and telecommunications industries and joins the biotech from Vodafone, where he served as director of global finance operations.

Prior to this, Fry spent 25 years at GlaxoSmithKline, during which time he held a number of senior roles including head of global financial services and chief financial officer for the pharmaceutical company's Italian business.

In his most recent role there, Fry oversaw all the financial aspects of the exchange of GSK's oncology business for Novartis Vaccines.

Dr Eliot Forster, chief executive officer of Immunocore, said: “I am delighted that Immunocore has been able to recruit someone of the calibre of Paul Fry, who will provide leadership across our financial operations as we continue our mission to become a world leader in biotechnology.

“As Immunocore continues to grow we are continually looking for outstanding individuals such as Paul to complement our team. He joins at an exciting time for the company and we very much look forward to working with him.”

21st October 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...